Phage therapy in pediatrics: the way forward for difficult-to-treat infections?

被引：5
|
作者：
Howard-Jones, Annaleise R. [1 ,2 ]
Iredell, Jonathan R. [2 ,3 ,4 ]
Khatami, Ameneh [2 ,5 ]
机构：
[1] Nepean Hosp, NSW Hlth Pathol Nepean, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia
[3] Westmead Inst Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia
[4] Westmead Hosp, Dept Infect Dis & Microbiol, Westmead, NSW, Australia
[5] Childrens Hosp Westmead, Dept Infect Dis & Microbiol, Westmead, NSW, Australia
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2022年 / 20卷 / 04期
关键词：
Bacteriophage; biofilm; therapeutic monitoring; multi-drug resistant organisms; pediatrics;
D O I：
10.1080/14787210.2022.1990755
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：487 / 491
页数：5
相关论文
共 50 条
  • [1] Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
    Uyttebroek, Saartje
    Chen, Baixing
    Onsea, Jolien
    Ruythooren, Fred
    Debaveye, Yves
    Devolder, David
    Spriet, Isabel
    Depypere, Melissa
    Wagemans, Jeroen
    Lavigne, Rob
    Pirnay, Jean-Paul
    Merabishvili, Maya
    De Munter, Paul
    Peetermans, Willy E.
    Dupont, Lieven
    Van Gerven, Laura
    Metsemakers, Willem-Jan
    LANCET INFECTIOUS DISEASES, 2022, 22 (08): : E208 - E220
  • [2] Safety and efficacy of phage therapy in difficult-to-treat infections: studies in Chinese literature
    Yin, Xin
    Zong, Zhiyong
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (10) : 1279 - 1281
  • [3] Safety and efficacy of phage therapy in difficult-to-treat infections: studies in Chinese literature
    Xin Yin
    Zhiyong Zong
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 1279 - 1281
  • [4] DIFFICULT-TO-TREAT INFECTIONS
    DEMARIE, S
    INTENSIVE CARE MEDICINE, 1990, 16 : S239 - S242
  • [5] Personalized bacteriophage therapy for difficult-to-treat infections
    Iredell, Jonathan
    Sinclair, Holly
    Khatami, Ameneh
    NATURE MICROBIOLOGY, 2024, : 1401 - 1402
  • [6] Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)
    Onsea, Jolien
    Uyttebroek, Saartje
    Chen, Baixing
    Wagemans, Jeroen
    Lood, Cedric
    Van Gerven, Laura
    Spriet, Isabel
    Devolder, David
    Debaveye, Yves
    Depypere, Melissa
    Dupont, Lieven
    De Munter, Paul
    Peetermans, Willy E.
    van Noort, Vera
    Merabishvili, Maia
    Pirnay, Jean-Paul
    Lavigne, Rob
    Metsemakers, Willem-Jan
    VIRUSES-BASEL, 2021, 13 (08):
  • [7] OFLOXACIN THERAPY OF DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIRESISTANT ORGANISMS
    ELBAZ, W
    OSMAN, L
    ABDELHAMID, T
    ELBOKL, M
    SABBOUR, MS
    CHEMIOTERAPIA, 1987, 6 (02): : 129 - 133
  • [8] CHEMOTHERAPEUTIC POSSIBILITIES IN DIFFICULT-TO-TREAT INFECTIONS
    WILLIAMS, JD
    INFECTION, 1980, 8 (06) : 309 - 313
  • [9] The challenges of difficult-to-treat Acinetobacter infections
    Richards, Guy A.
    Perovic, Olga
    Brink, Adrian J.
    CLINICAL MICROBIOLOGY REVIEWS, 2024,
  • [10] USE OF CEFOXITIN SODIUM IN DIFFICULT-TO-TREAT INFECTIONS
    NAIR, SR
    CHERUBIN, CE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 : 167 - 178
12345